"During construction, enter off Connell Avenue and exit through the parking lot south of the Eye Institute."

During the past decade, Medical College of Wisconsin, The Eye Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical College of Wisconsin, The Eye Institute" #1 sponsor was "Horizon Pharma USA, Inc." with 3 trials, followed by "Alkeus Pharmaceuticals, Inc." with 1 trials sponsored, "Jaeb Center for Health Research" with 1 trials sponsored, "Johns Hopkins University" with 1 trials sponsored and "Kubota Vision Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical College of Wisconsin, The Eye Institute" #1 collaborator was "Centro Medico ABC" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "Emory University" with 1 trials as a collaborator, "Foundation Fighting Blindness" with 1 trials as a collaborator and "Massachusetts Eye and Ear Infirmary" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Medical College of Wisconsin, The Eye Institute" are "Retinitis Pigmentosa" (2 trials), "Stargardt Disease" (2 trials), "Thyroid Eye Disease" (2 trials), "Autosomal Recessive Stargardt Disease 1 (ABCA4-related)" (1 trials) and "Epilepsies, Partial" (1 trials). Many other conditions were trialed in "Medical College of Wisconsin, The Eye Institute" in a lesser frequency.

Most popular intervention types in "Medical College of Wisconsin, The Eye Institute" are "Drug" (9 trials), "Biological" (2 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Teprotumumab" (2 trials), "ALK-001" (1 trials), "Acyclovir" (1 trials) and "Bevasiranib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical College of Wisconsin, The Eye Institute" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Medical College of Wisconsin, The Eye Institute". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Medical College of Wisconsin, The Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medical College of Wisconsin, The Eye Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".